Noile-Immune Biotech is a national cancer research center specializing in the development of cancer immunotherapies.
Neurymune Biotech Co., Ltd. is a national cancer research center specializing in the development of cancer immunotherapies based on CAR-T cell therapy and a venture company from Yamaguchi University.They aim to be a leading company responsible for the next generation in the field of cancer immunotherapy.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Mar 22, 2021 | Series C | ¥2.38B | 2 | BiGEN | — | Detail |
May 31, 2018 | Series Unknown | ¥60M | 2 | — | — | Detail |
Sep 4, 2017 | Corporate Round | ¥1B | 1 | Takeda | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
BiGEN | Yes | Series C |
Takeda | Yes | Corporate Round |
Healthcare Innovation | — | Series C |
SAIKYO | — | Series Unknown |